DHPYX | JVMAX | DHPYX / JVMAX | |
Total Expense Ratio | 0.65 | 1.12 | 58% |
Annual Report Gross Expense Ratio | 0.65 | 1.13 | 58% |
Fund Existence | 11 years | 28 years | - |
Gain YTD | -2.037 | -2.360 | 86% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 500000 | 1000 | 50,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 132M | 20.6B | 1% |
Annual Yield % from dividends | 1.29 | 0.63 | 205% |
Returns for 1 year | -4.93 | -8.80 | 56% |
Returns for 3 years | 1.95 | 4.03 | 48% |
Returns for 5 years | 63.25 | 49.78 | 127% |
Returns for 10 years | 57.12 | 26.12 | 219% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SCHV | 26.20 | 0.13 | +0.50% |
Schwab US Large-Cap Value ETF™ | |||
BMEZ | 14.27 | 0.03 | +0.21% |
BlackRock Health Sciences Term Trust | |||
SEIQ | 35.17 | 0.04 | +0.12% |
SEI Enhanced US Large Cap Qual Fac ETF | |||
APRZ | 32.98 | N/A | N/A |
TrueShares Structured Outcome April ETF | |||
YLDE | 50.90 | -0.10 | -0.20% |
Franklin ClearBridge Enhanced Inc ETF |